Willem Birkhoff

<scp>DNL</scp>104, a Centrally Penetrant <scp>RIPK</scp>1 Inhibitor, Inhibits <scp>RIP</scp>1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers

Hendrika W. Grievink, Jules A. A. C. Heuberger, Fen Huang et al. · Clinical Pharmacology & Therapeutics · 2019 · 70 citations · Full text

The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy

Heidemarie Kletzl, Anne Marquet, Andreas Günther et al. · Neuromuscular Disorders · 2018 · 41 citations

Amyotrophic Lateral Sclerosis, Genetics, Degenerative Disease +7

Levofloxacin‐Induced QTc Prolongation Depends on the Time of Drug Administration

Laura Kervezee, Verena Gotta, Jasper Stevens et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 22 citations · Full text

Heart Failure, Pharmacotherapy, Drug-induced Qtc Prolongation +16

Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis

Matthijs D. Kruizinga, Willem Birkhoff, Michiel J. van Esdonk et al. · British Journal of Clinical Pharmacology · 2019 · 20 citations · Full text

Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach

Laura Kervezee, Jasper Stevens, Willem Birkhoff et al. · British Journal of Clinical Pharmacology · 2015 · 15 citations · Full text